Skip to main content
Open Access Publications from the University of California

Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers.

  • Author(s): Armstrong, William B
  • Taylor, Thomas H
  • Meyskens, Frank L, Jr
  • et al.
Main Content
Current View